Basit öğe kaydını göster

Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study

dc.contributor.authorBuggage, Ronald
dc.contributor.authorSaroj, Namrata
dc.contributor.authorSundaram, Preethi A.
dc.contributor.authorOzyazgan, Yilmaz
dc.contributor.authorNguyen, Quan Dong
dc.contributor.authorSoo, Yuhwen
dc.contributor.authorVarona, Rafael V.
dc.contributor.authorCorp-dit-Genti, Valerie
dc.contributor.authorCheng, Yenchieh
dc.contributor.authorHeissigerova, Jarmila
dc.contributor.authorCallanan, David
dc.contributor.authorde Smet, Marc D.
dc.contributor.authorSrivastava, Sunil K.
dc.contributor.authorKarkanova, Michala
dc.contributor.authorGarcia-Garcia, Olga
dc.contributor.authorKADAYIFÇILAR, SİBEL
dc.contributor.authorVitti, Robert
dc.contributor.authorErickson, Kristine
dc.contributor.authorAthanikar, Aditya
dc.contributor.authorChu, Karen
dc.date.accessioned2021-03-05T14:57:25Z
dc.date.available2021-03-05T14:57:25Z
dc.date.issued2019
dc.identifier.citationHeissigerova J., Callanan D., de Smet M. D. , Srivastava S. K. , Karkanova M., Garcia-Garcia O., KADAYIFÇILAR S., Ozyazgan Y., Vitti R., Erickson K., et al., "Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study", OPHTHALMOLOGY, cilt.126, ss.428-437, 2019
dc.identifier.issn0161-6420
dc.identifier.otherav_b9aadbeb-c5be-4fed-81a7-3b0425e4fcc3
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/123521
dc.identifier.urihttps://doi.org/10.1016/j.ophtha.2018.09.044
dc.description.abstractPurpose: To assess efficacy and safety of sarilumab, a human anti-interleukin-6 receptor antibody, for treatment of posterior segment noninfectious uveitis (NIU).
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectCerrahi Tıp Bilimleri
dc.subjectGöz Hastalıkları ve Cerrahisi
dc.subjectOFTALMOLOJİ
dc.titleEfficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study
dc.typeMakale
dc.relation.journalOPHTHALMOLOGY
dc.contributor.departmentCharles University Prague , ,
dc.identifier.volume126
dc.identifier.issue3
dc.identifier.startpage428
dc.identifier.endpage437
dc.contributor.firstauthorID263255


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster